Rockwell Medical
RMTI
Market cap $68.2M

2.11 USD

+0.03

1.44%

At close Dec 23, 4:00 PM EST

1 day

1.44%

5 days

-1.40%

1 month

-8.66%

3 months

-46.17%

6 months

14.67%

Year to date

13.44%

1 year

9.33%

5 years

-92.54%

10 years

-97.74%

About: Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Employees: 237

Healthcare Pharmaceutical Preparations

0

Funds holding %

of 6,809 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

610% more call options, than puts

Call options by funds: $1.97M | Put options by funds: $277K

575% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 4

239% more capital invested

Capital invested by funds: $11.1M [Q2] → $37.6M (+$26.5M) [Q3]

129% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 7

74% more funds holding

Funds holding: 31 [Q2] → 54 (+23) [Q3]

9.75% more ownership

Funds ownership: 20.73% [Q2] → 30.48% (+9.75%) [Q3]

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$5

137%

upside

Avg. target

$6

184%

upside

High target

$7

232%

upside

2 analyst ratings

2 positive

100%

0 neutral

0%

0 negative

0%

HC Wainwright & Co. Raghuram Selvaraju 37% 1-year accuracy 117 / 313 met price target	232%upside $7	Buy Reiterated	23 Dec 2024
Rodman & Renshaw Brandon Folkes 54% 1-year accuracy 7 / 13 met price target	137%upside $5	Buy Initiated	14 Nov 2024

See Analyst Rankings

Financial journalist opinion

Based on 6 articles about RMTI published over the past 30 days

Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical is the leading supplier of liquid bicarbonate in the United States.

Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services

UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card

Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions

UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card

Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card

Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions

Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card

Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card

Vote “ FOR ” All Four Kellner Group Nominees for Urgently Needed Change

Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card

Rockwell Medical Promotes Jesse Neri to Chief Financial Officer

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Jesse Neri has been instrumental in strengthening Rockwell Medical's financial infrastructure and developing a stronger financial organization.

Rockwell Medical Promotes Jesse Neri to Chief Financial Officer

Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's DAMX45 dry acid concentrate mix system is 510(k) approved to be used exclusively with the Company's dry acid concentrate powders.

Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System

Rockwell Medical Expands Distribution in the Philippines

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will be the exclusive supplier of all dry hemodialysis concentrates products to Nephro Group.

Rockwell Medical Expands Distribution in the Philippines

Rockwell Medical's Dip Gives A Speculative Opportunity

Despite a 39% stock drop yesterday, Rockwell Medical's strong Q3 results and upcoming catalyst provide a solid buying opportunity for risk-takers. The stock's dip was due to reduced orders from its largest customer, but Rockwell is diversifying its customer base and entering the at-home dialysis market. Strategic initiatives, including new supply contracts and product line growth, are expected to mitigate revenue reductions and generate future growth.

Rockwell Medical's Dip Gives A Speculative Opportunity

Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Heather Hunter - Senior Vice President & Chief Corporate Affairs Officer Mark Strobeck - President & Chief Executive Officer Jesse Neri - Senior Vice President of Finance Conference Call Participants Anthony Venditti - Maxim Group Operator Good morning and welcome to Rockwell Medical's Third Quarter 2024 Results Conference Call and Webcast. Please note, this event is being recorded.

Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript

Zacks Investment Research

Rockwell Medical (RMTI) Surpasses Q3 Earnings and Revenue Estimates

Rockwell Medical (RMTI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.07 per share a year ago.

Rockwell Medical (RMTI) Surpasses Q3 Earnings and Revenue Estimates

See News Rankings

Charts implemented using Lightweight Charts™